MARK F DALTON Insider Trading $PGNX PROGENICS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK F DALTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK F DALTON. MARK F DALTON is Director in PROGENICS PHARMACEUTICALS INC ($PGNX).
MARK F DALTON in PROGENICS PHARMACEUTICALS INC
Trading Symbol: PGNXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK F DALTON: Director
Holdings: 78,500 shares
Current Value: $748,105
Latest Transaction: Jul 06 2011
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK F DALTON in PROGENICS PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2011 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 7.40 | 10,000 | 74,000 | 10,000 | |
Jul 06 2010 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 5.35 | 10,000 | 53,500 | 10,000 | |
Jul 06 2009 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 5.33 | 10,000 | 53,300 | 10,000 | |
Jul 07 2008 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 16.05 | 10,000 | 160,500 | 10,000 | |
May 16 2008 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | M | 6.66 | 2,500 | 16,650 | 0 | |
May 16 2008 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | M | 5.02 | 2,500 | 12,550 | 0 | |
May 16 2008 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | M | 4.41 | 2,500 | 11,025 | 0 | |
May 16 2008 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Buy | M | 5.02 | 2,500 | 12,550 | 78,500 | 76 K to 78.5 K (+3.29 %) |
May 16 2008 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Buy | M | 6.66 | 2,500 | 16,650 | 76,000 | 73.5 K to 76 K (+3.40 %) |
May 16 2008 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Buy | M | 4.41 | 2,500 | 11,025 | 73,500 | 71 K to 73.5 K (+3.52 %) |
Jul 05 2007 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 22.01 | 10,000 | 220,100 | 10,000 | |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 24.26 | 10,000 | 242,600 | 10,000 | |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 24.26 | 10,000 | 242,600 | 10,000 | |
Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | DALTON MARK F | Director | Option Exercise | A | 21.39 | 10,000 | 213,900 | 10,000 |
Page: 1